Introduction to the College on Problems of Drug Dependence Special Issue: Contemporary Advances in Opioid Neuropharmacology

Drug and Alcohol Dependence

Volumn 108, Issue 3, 2010, Pages 153-155

  Walsh, Sharon L ^a   Unterwald, Ellen M ^b   Izenwasser, Sari ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Abuse; Analgesia; Genetics; Molecular biology; Opioid; Pharmacology; Receptor

Indexed keywords

G PROTEIN COUPLED RECEPTOR; OPIATE; OPIATE RECEPTOR;

ANALGESIA; DRUG ABUSE; DRUG DEPENDENCE; EDITORIAL; ENDOCYTOSIS; MEMBRANE TRANSPORT; MOLECULAR MECHANICS; NEUROBIOLOGY; NEUROMODULATION; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANALGESICS, OPIOID; ANIMALS; HUMANS; NEUROPHARMACOLOGY; OPIOID-RELATED DISORDERS; RECEPTORS, OPIOID; SUBSTANCE-RELATED DISORDERS;

EID: 77952422756     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.03.001     Document Type: Editorial

References (13)

1. Archer, S., 1998. The early history of the INRC (1969-1975) (Accessed 15.02.10). http://www.inrcworld.org/history.htm.
2. Bond C., LaForge K.S., Tian M., Melia D., Zhang S., Borg L., Gong J., Schluger J., Strong J.A., Leal S.M., Tischfield J.A., Kreek M.J., Yu L. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:9608-9613.
3. Campbell N.D., Olsen J.P., Walden L. The Narcotic Farm The Rise and Fall of America's First Prison for Drug Addicts 2008, Abrams Books, New York.
4. Compton W.M., Volkow N.D. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006, 81:103-107.
5. Eddy N.B. The National Research Council Involvement in the Opiate Problem 1973, National Academy of Sciences, Washington, DC.
6. Evans C.J., Walwyn W.M., Miiotto K.A. Opioid pharmaceuticals and addiction; the issues, and research directions seeking solutions. Drug Alcohol Depend. 2010, 108:156-165.
7. Kreek M.J. Commentary: overview and historical perspective of four papers presented on research related to the endogenous opioid system. Drug Alcohol Depend. 2010, 108:195-199.
8. Mague S.D., Blendy J.A. OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend. 2010, 108:172-182.
9. Mague S.D., Isiegas C., Huang P., Liu-Chen L.-Y., Lerman C., Blendy J.A. Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behaviors. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:10847-10852.
10. May E.L., Jacobson A.E. The committee on problems of drug dependence: a legacy of the national academy of sciences. A historical account. Drug Alcohol Depend. 1989, 23:183-218.
11. Trigo J.M., Martin-Garcia E.B., Robledo P., Maldonado R. The endogenous opioid system: a common substrate in drug addiction. Drug Alcohol Depend. 2010, 108:183-194.
12. Urban J.D., Clarke W.P., von Zastrow M., Nichols D.E., Kobilka B., Weinstein H., Javitch J.A., Roth B.L., Christopoulos A., Sexton P.M., Miller K.J., Spedding M., Mailman R.B. Functional selectivity and classical concepts of quantitative pharmacology. J. Pharmacol. Exp. Ther. 2007, 320:1-13.
13. von Zastrow M. Regulation of opioid receptors by endocytic membrane traffic: Mechanisms and translational implications. Drug Alcohol Depend. 2010, 108:166-171.